Imputation of Baseline LDL Cholesterol Concentration in Patients with Familial Hypercholesterolemia on Statins or

Isabelle Ruel1, Sumayah Aljenedil1, Iman Sadri1

  • 1Research Institute of the McGill University Health Centre, Royal Victoria Hospital, Montreal, QC, Canada.

Clinical Chemistry
|October 18, 2017
PubMed

Insights

A new algorithm accurately estimates baseline LDL cholesterol (LDL-C) for Familial Hypercholesterolemia (FH) patients, even if they are already on statin therapy. This tool aids in diagnosing FH and initiating timely treatment for cardiovascular disease risk.

Area of Science:

  • Cardiovascular Genetics
  • Lipid Metabolism
  • Clinical Diagnostics

Background:

  • Familial Hypercholesterolemia (FH) is a common genetic disorder characterized by elevated LDL cholesterol (LDL-C), increasing the risk of premature atherosclerotic cardiovascular disease (ASCVD).
  • Accurate diagnosis of FH is crucial for initiating lifelong management, including intensive pharmacological therapy.
  • Baseline LDL-C levels are essential for FH diagnosis but often unavailable due to prior statin treatment.

Purpose of the Study:

  • To validate a novel algorithm designed to estimate baseline LDL-C concentrations in patients with FH.
  • To assess the algorithm's utility in clinical settings where baseline LDL-C measurements are missing.

Main Methods:

  • A cohort of 1297 patients was initially examined to validate the imputation algorithm.
  • Baseline LDL-C was compared with imputed values obtained within 18 months of statin therapy initiation.
  • Data from 951 patients, after exclusions for missing data or non-standard treatments, were analyzed.

Main Results:

  • The mean baseline LDL-C was 243.0 mg/dL, while the mean imputed baseline LDL-C was 244.2 mg/dL (P = 0.48), showing no significant difference.
  • The algorithm demonstrated accuracy in estimating pre-treatment LDL-C levels.
  • No variations in treatment response were observed based on patient sex or the specific statin/ezetimibe used.

Conclusions:

  • A validated method for estimating baseline LDL-C in FH patients is now available.
  • This tool can assist clinicians in diagnosing FH, particularly when baseline lipid levels are not recorded.
  • Improved diagnostic capabilities can lead to earlier intervention and better management of cardiovascular risk in FH patients.
Abstract

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...